Avery Dennison Corporation (NYSE: AVY) is a global materials science and digital identification solutions company that provides branding and information labeling solutions, including pressure-sensitive materials, radio-frequency identification (RFID) inlays and tags, and a variety of converted products and solutions. The company designs and manufactures a wide range of labeling and functional materials that enhance branded packaging, carry or display information that connects the physical and the digital, and improve customers’ product performance. The company serves an array of industries worldwide, including home and personal care, apparel, e-commerce, logistics, food and grocery, pharmaceuticals and automotive. The company employs approximately 36,000 employees in more than 50 countries. Reported sales in 2022 were $9.0 billion.

Bluesight solves supply chain inefficiencies and reduces risk by providing actionable analytics for every step of the medication lifecycle. Through our suite of Medication Intelligence™️ solutions, Bluesight brings simplicity, visibility, and predictability to the complex world of medication management. To date, more than 1,000 U.S. and Canadian hospitals utilize Bluesight solutions to optimize their hospital’s efficiency. Bluesight focuses on providing comprehensive, item-level data that empowers providers to make informed, accurate decisions. These solutions include RFID-enabled inventory management, controlled substance diversion prevention software and medication purchasing optimization.

CCL Healthcare, a division of CCL Label, is focused on producing secondary packaging within cGMP facilities. We pride ourselves in partnering globally with companies of all sizes and manufacturing our products locally to our partners. That is why we have 33 cGMP facilities worldwide and are growing. With over 65 years of printing experience, CCL Healthcare knows quality matters. That is why we have invested heavily into 100% Vision Inspection Systems and deployed the most rigorous quality assurance process in the industry. What does this mean for our partners? CCL Healthcare is dedicated to providing our partners with the lowest cost of ownership in the industry. CCL Healthcare works with the industry leaders in the development of new RFID tags, inlay sizes, software and systems integrators to ensure the successful launch of your next RFID project. CCL has invested heavily into highly trained personnel and new state of the art equipment. With our skilled staff we are able innovate not only at the product level but at the machinery level modifying equipment to push the boundaries to achieve what was once not possible yesterday to the what is possible today.

West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products, including those used to treat severe respiratory distress symptoms associated with COVID-19. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. Nephron fills the needs of patients and health care professionals as they arise nationwide, and recently opened a CLIA-certified diagnostics lab that offers COVID-19 tests for people across South Carolina.

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2019 sales of USD 9.7 billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.